Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs
ClinicalTrials.gov study NCT04978038. IPD Sharing: NO. Countries: 1. Publications: 0.
Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia
ClinicalTrials.gov study NCT05087225. IPD Sharing: NO. Countries: 1. Publications: 0.
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
ClinicalTrials.gov study NCT05550142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03908671. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
ClinicalTrials.gov study NCT06672055. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
ClinicalTrials.gov study NCT05743335. IPD Sharing: NO. Countries: 1. Publications: 0.
VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection
ClinicalTrials.gov study NCT05364242. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647
ClinicalTrials.gov study NCT05105048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms
ClinicalTrials.gov study NCT06019702. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
ClinicalTrials.gov study NCT07285265. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults
ClinicalTrials.gov study NCT06028347. IPD Sharing: YES. Countries: 1. Publications: 0.
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
ClinicalTrials.gov study NCT05075538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
ClinicalTrials.gov study NCT05683457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes
ClinicalTrials.gov study NCT06919796. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
ClinicalTrials.gov study NCT00204516. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
ClinicalTrials.gov study NCT05894525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
ClinicalTrials.gov study NCT05907044. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants
ClinicalTrials.gov study NCT05260437. IPD Sharing: YES. Countries: 1. Publications: 0.
Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients
ClinicalTrials.gov study NCT07390968. IPD Sharing: NO. Countries: 1. Publications: 0.
mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs
ClinicalTrials.gov study NCT05686161. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.